Identification
NameGantacurium Chloride
Accession NumberDB05710
TypeSmall Molecule
GroupsInvestigational
Description

Gantacurium Chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.

Structure
Thumb
Synonyms
AV430A
External IDs AV-4430A / GW-280430 / GW-280430A / GW280430A
Product Ingredients Not Available
Approved Prescription ProductsNot Available
Approved Generic Prescription ProductsNot Available
Approved Over the Counter ProductsNot Available
Unapproved/Other Products Not Available
International BrandsNot Available
Brand mixturesNot Available
CategoriesNot Available
UNIILEY8QK99UR
CAS number213998-46-0
WeightAverage: 1064.49
Monoisotopic: 1062.381438
Chemical FormulaC53H69Cl3N2O14
InChI KeySDIFKXLSGXCGEN-WJUBNSBASA-L
InChI
InChI=1S/C53H69ClN2O14.2ClH/c1-55(19-15-34-26-41(59-3)43(61-5)30-37(34)40(55)23-33-24-45(63-7)51(67-11)46(25-33)64-8)17-13-22-70-53(58)39(54)32-49(57)69-21-14-18-56(2)20-16-35-27-42(60-4)44(62-6)31-38(35)50(56)36-28-47(65-9)52(68-12)48(29-36)66-10;;/h24-32,40,50H,13-23H2,1-12H3;2*1H/q+2;;/p-2/b39-32-;;/t40-,50+,55-,56+;;/m1../s1
IUPAC Name
SMILES
[Cl-].[Cl-].COC1=CC(C[[email protected]@H]2C3=CC(OC)=C(OC)C=C3CC[[email protected]@+]2(C)CCCOC(=O)C(\Cl)=C\C(=O)OCCC[[email protected]@+]2(C)CCC3=CC(OC)=C(OC)C=C3[[email protected]@H]2C2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Pharmacology
Indication

Investigated for use/treatment in anesthesia (unspecified).

Structured Indications Not Available
Pharmacodynamics

Gantacurium chloride administered to anesthetized and ventilated healthy volunteers, caused dose dependent transient decrease in arterial blood pressure, mild histamine release at higher doses and no consistent changes in pulmonary compliance.

Mechanism of actionNot Available
Related Articles
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
Metabolism

The pharmacokinetic parameters are consistent with in situ rapid inactivation by plasma cysteine.

Route of eliminationNot Available
Half life

3.09±0.21 minutes

ClearanceNot Available
ToxicityNot Available
Affected organisms
  • Humans and other mammals
PathwaysNot Available
Pharmacogenomic Effects/ADRs Not Available
Interactions
Drug Interactions Not Available
Food InteractionsNot Available
References
Synthesis ReferenceNot Available
General References
  1. Heerdt PM, Kang R, The' A, Hashim M, Mook RJ Jr, Savarese JJ: Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs. Anesthesiology. 2004 Apr;100(4):846-51. [PubMed:15087619 ]
  2. Savarese JJ, Belmont MR, Hashim MA, Mook RA Jr, Boros EE, Samano V, Patel SS, Feldman PL, Schultz JA, McNulty M, Spitzer T, Cohn DL, Morgan P, Wastila WB: Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium. Anesthesiology. 2004 Apr;100(4):835-45. [PubMed:15087618 ]
External Links
ATC CodesNot Available
AHFS CodesNot Available
PDB EntriesNot Available
FDA labelNot Available
MSDSNot Available
Clinical Trials
Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2CompletedTreatmentHealthy Volunteers1
Pharmacoeconomics
ManufacturersNot Available
PackagersNot Available
Dosage formsNot Available
PricesNot Available
PatentsNot Available
Properties
StateSolid
Experimental PropertiesNot Available
Predicted Properties
PropertyValueSource
Water Solubility2.9e-05 mg/mLALOGPS
logP4.58ALOGPS
logS-7.6ALOGPS
Predicted ADMET featuresNot Available
Spectra
Mass Spec (NIST)Not Available
SpectraNot Available
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIsoquinolines and derivatives
Sub ClassBenzylisoquinolines
Direct ParentBenzylisoquinolines
Alternative Parents1-phenyltetrahydroisoquinolines / Phenoxy compounds / Anisoles / Methoxybenzenes / Alkyl aryl ethers / Aralkylamines / Fatty acid esters / Dicarboxylic acids and derivatives / Vinylogous halides / Tetraalkylammonium salts
SubstituentsBenzylisoquinoline / 1-phenyltetrahydroisoquinoline / Tetrahydroisoquinoline / Phenoxy compound / Phenol ether / Anisole / Methoxybenzene / Alkyl aryl ether / Aralkylamine / Fatty acid ester
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Drug created on November 18, 2007 11:27 / Updated on September 01, 2017 11:25